Drugs / iQ-007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06899230 | Apr 2025 → Jan 2026 overdue | focal epilepsy | iQure Australia Pty Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iQ-007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06899230 ↗ |
| Route | Oral | “administration of a single oral dose of iQ-007” NCT06899230 ↗ |